Artwork
iconShare
 
Manage episode 449592886 series 2902118
Content provided by ACCP JOURNALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ACCP JOURNALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Explore the basis for and controversy surrounding the US Food and Drug Administration requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.2034.

  continue reading

162 episodes